Company

AVEO PHARMACEUTICALS, INC. (0001325879)

Standardized SEC financial data for AVEO PHARMACEUTICALS, INC. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001325879 · Pharmaceutical Preparations.

Gross margin

88.8%

Operating margin

-117.2%

Net margin

-126.1%

Revenue growth (YoY)

602.7%

Return on equity

-116.3%

Free cash flow

-$57.3M

Debt / equity

0.35×

Current ratio

5.59×

Ratios for fiscal year 2021, standardized from SEC filings.

Income statement

USD	FY2017	FY2018	FY2019	FY2020	FY2020	FY2021
Revenue	$7.6M	$5.4M	$28.8M	$20.0M	$6.0M	$42.3M
Cost of revenue	—	—	$0	—	$0	$4.7M
Gross profit	—	—	$28.8M	—

Balance sheet

USD	FY2019	FY2020	FY2020	FY2020	FY2020	FY2021
Cash & equivalents	$47.7M	—	—	—	$61.8M	$87.3M
Inventory	—	—	—	—	$0	$1.7M
Total current assets	$50.6M	—	—	—	$65.5M

Cash flow

USD	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021
Operating cash flow	-$31.1M	-$19.2M	-$25.0M	-$2.9M	-$38.0M	-$57.3M
Capital expenditures	$7K	—	—	$0	$363K	$0
Free cash flow	-$31.1M	—	—	-$2.9M	-$38.3M

Get 0001325879 data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001325879/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001325879/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View 0001325879 filings on SEC EDGAR →